Retour sur lavenir.net
   AGEAS 72.750 € (0,00 %)     UCB 219.400 € (-1,08 %)     ARGENX SE 760.600 € (-0,05 %)     KBC 130.950 € (+1,00 %)     COLRUYT 38.360 € (+0,31 %)     VGP 80.200 € (0,00 %)     SIPEF 96.900 € (+4,53 %)     MELEXIS 72.050 € (-0,62 %)     SYENSQO 79.450 € (-1,67 %)     WDP 21.240 € (-0,65 %)     RECTICEL 12.600 € (+0,64 %)     AB INBEV 68.640 € (-0,06 %)     D'IETEREN GROUP 175.700 € (-0,51 %)     UMICORE 23.640 € (-2,39 %)     SOLVAC NOM(RETAIL) 81.500 € (+2,52 %)     VAN DE VELDE 29.800 € (+0,34 %)     AZELIS GROUP 11.770 € (-1,26 %)     CARE PROPERTY INV. 12.120 € (-0,33 %)     KINEPOLIS GROUP 40.950 € (+0,74 %)     GBL 75.900 € (+0,20 %)     CMB.TECH 14.520 € (+0,83 %)     KBC ANCORA 92.400 € (+0,98 %)     SOLVAY 25.920 € (-2,70 %)     SHURGARD 24.050 € (+0,84 %)     DEME GROUP 167.400 € (+0,24 %)     BPOST 1.392 € (-0,43 %)     AEDIFICA 68.200 € (+0,15 %)     FLUXYS BELGIUM D 20.100 € (0,00 %)     IBA 16.100 € (+1,77 %)     PROXIMUS 6.220 € (-0,72 %)     BEKAERT 37.950 € (+0,26 %)     GIMV 43.950 € (0,00 %)     ONWARD MEDICAL 2.405 € (+0,63 %)     NYRSTAR 0.061 € (0,00 %)     ACKERMANS V.HAAREN 264.600 € (+0,23 %)     TESSENDERLO 21.000 € (-1,41 %)     CAMPINE 201.000 € (-0,50 %)     SOFINA 249.400 € (+0,24 %)     OXURION 0.003 € (+7,69 %)     OPTION 3.910 € (-2,74 %)     TUBIZE-FIN 184.200 € (-1,39 %)     XIOR 27.600 € (+0,18 %)     ELIA GROUP 132.000 € (+0,69 %)     BARCO 7.990 € (+0,50 %)     ASCENCIO 51.900 € (0,00 %)     LOTUS BAKERIES 12 680.000 € (+2,76 %)     TEXAF 41.400 € (-0,96 %)     EVS 28.150 € (+0,72 %)     JENSEN-GROUP 73.000 € (+0,27 %)     BREDERODE 103.400 € (+0,39 %)     MONTEA 66.200 € (-0,75 %)     CFE 11.800 € (-1,67 %)     VASTNED 29.050 € (0,00 %)     ONTEX GROUP 2.500 € (+0,20 %)     DECEUNINCK 2.220 € (0,00 %)     VIOHALCO 17.920 € (-0,44 %)     BIOTALYS 2.450 € (-1,21 %)     FAGRON 22.300 € (+0,45 %)     RETAIL ESTATES 64.700 € (0,00 %)     ATENOR 1.265 € (-0,39 %)  
   EXOSENS 65.350 € (-0,23 %)     FDJ UNITED 22.160 € (+0,64 %)     CVC CAPITAL 15.290 € (+0,46 %)     EMEIS 14.280 € (+1,42 %)     ATON 0.012 € (+7,02 %)     PLANISWARE 24.800 € (+1,43 %)     OPMOBILITY 12.470 € (-0,08 %)     PERNOD RICARD 68.440 € (+0,71 %)     ASM INTERNATIONAL 901.400 € (+0,40 %)     L'OREAL 384.600 € (+1,09 %)     BNP PARIBAS ACT.A 113.760 € (+1,57 %)     GENFIT 13.640 € (+3,96 %)     COMPAGNIE ODET 1 318.000 € (+0,30 %)     EIFFAGE 121.800 € (-0,25 %)     EUTELSAT COMMUNIC. 2.262 € (+4,63 %)     SOCIETE GENERALE 84.230 € (+1,34 %)     SCHNEIDER ELECTRIC 311.250 € (+0,08 %)     TOMTOM 4.092 € (+0,44 %)     FASTNED 35.100 € (+7,01 %)     SAINT GOBAIN 84.600 € (+0,43 %)     EURAZEO 51.800 € (+0,10 %)     ELIS 24.660 € (+0,41 %)     LVMH 467.950 € (+0,65 %)     ASML HOLDING 1 580.400 € (+0,86 %)     ESSILORLUXOTTICA 164.600 € (+0,12 %)     DANONE 67.500 € (+0,72 %)     IMCD 95.860 € (-1,88 %)     UNILEVER 53.830 € (+0,35 %)     UMG 14.630 € (-1,68 %)     GTT 202.200 € (+0,10 %)     SANOFI 75.350 € (-0,09 %)     STMICROELECTRONICS 47.495 € (-1,12 %)     BE SEMICONDUCTOR 231.400 € (-0,17 %)     DBV TECHNOLOGIES 2.460 € (+0,82 %)     TOTALENERGIES 75.280 € (-0,33 %)     AIR LIQUIDE 169.260 € (-0,63 %)     Coca-ColaEuropacif 92.300 € (-0,43 %)     SHELL PLC 38.610 € (-0,23 %)     BOLLORE 3.840 € (+1,21 %)     CROSSJECT 1.490 € (+1,50 %)     CSG 18.958 € (+2,75 %)     DASSAULT SYSTEMES 21.130 € (-1,26 %)     AALBERTS NV 44.740 € (+0,36 %)     EUROFINS SCIENT. 70.220 € (+0,89 %)     AXA 44.940 € (+0,47 %)     PROSUS 37.900 € (-1,97 %)     ORANGE 16.170 € (+0,12 %)     THEON INTERNAT 38.300 € (+1,11 %)     SARTORIUS STED BIO 181.200 € (+0,50 %)     VALNEVA 2.416 € (-1,81 %)     SPIE 47.700 € (+0,04 %)     SAFRAN 365.000 € (+0,39 %)     WORLDLINE 12.406 € (+4,99 %)     HAFFNER ENERGY 0.645 € (-7,06 %)     VALLOUREC 18.220 € (-0,33 %)     HEINEKEN 73.400 € (-0,73 %)     WATERA 1.420 € (-4,38 %)     REXEL 37.790 € (+0,48 %)     ADYEN 1 031.200 € (+13,32 %)     GOLD BY GOLD 4.950 € (0,00 %)  
News Réglementées
13/08/2026 09:00

Original-Research: INDUS Holding AG (von NuWays AG): BUY

Original-Research: INDUS Holding AG - from NuWays AG

13.08.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to INDUS Holding AG

Company Name:INDUS Holding AG
ISIN:DE0006200108
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 41
Target price on sight of:12 months
Last rating change:
Analyst:Sarah Hellemann

Q2 26: Broad-based growth accelerated by tungsten catalyst

Yesterday, INDUS released its H1 26 report. As outlined by preliminary figures published end of July, Q2 came in exceptionally strong. In detail:

Strong order intake across segments. Order intake rose by 29.7% yoy, led by pricing related higher order values at BETEK and broad improvements across portfolio companies. The backlog rose by 18.6% yoy to € 789m and H1 book-to-bill to 1.14x (eNuW: 1.07x; H1'25 1.03x).

Strong Q2 performance. Sales grew by 20.6% yoy to € 524m. This was mainly driven by an exceptional Materials Solutions performance especially supported by portfolio company BETEK. This included 2pp of inorganic growth from acquisitions. Adj. EBITA soared by 160% yoy to € 81.1m, mainly driven by significantly stronger margins in Material Solutions orders. The adj. EBITA margin expanded by 8.3pp to 15.5%.

Materials Solutions soared from tungsten special situation. Sales surged by 47.4% yoy to € 209m (eNuW: € 202m), mainly driven by pricing effects in tungsten products of portfolio company BETEK, but also volume and market share gains. Notably, other portfolio companies in the segment also cumulatively contributed positively. Adj. EBITA expanded by 441% yoy to € 56.3m (eNuW: € 55.3m), largely driven by higher margins on BETEK orders. The adj. EBITA margin more than tripled, up 19.6pp to 26.9%.

Engineering proved resilient in a challenging market environment. The segment grew by 9.1% yoy to € 149m (eNuW: € 147m) in sales, partially driven by inorganic growth of 5.5% yoy, but also higher organic growth compared to the German engineering sector. Adj. EBITA improved 10.5% yoy to € 10.5m (eNuW: € 8.1m), slightly disproportionate to revenue growth. The segment slightly raised its adj. EBITA margin by 0.1pp yoy to 7.1%.

Infrastructure benefitted from above-average temperatures. Sales rose by 6.3% yoy to € 166m yet came in slightly behind our estimate of € 175m, as both regular growth and the warm-June effect were less pronounced than assumed. In June, above-average temperatures had caused an upturn in building inlet and sealing systems business as well as air-conditioning devices. Inorganic growth contributed 1.8% from acquisitions made in 2025. Adj. EBITA strengthened by 26.7% yoy to € 20.9m (eNuW: € 18.7m), supported by a mix of higher demand disproportionately reflecting on the bottom-line and positive product mix-effects. The adj. EBITA margin rose by 2pp yoy to 12.6%.

FCF improved by € 37.2m to € -36.9m at end of Q2, compared to the FCF in Q1, which had been impacted by high working capital investments. The improvement was significantly above the + € 15.7m in Q2 2025, as the operating CF strengthened by 57.6% yoy to € 44.6m.

Special situation reflects in strong EPS contribution. INDUS delivered a Q2 EPS contribution of € 1.85/share (up 270% yoy; eNuW € 1.91), bringing total YTD EPS to € 2.49 (+ 119.5% yoy). In our view further strong EPS development in H2 26 could provide potential for accelerated inorganic growth (in addition to only € 16.6m of the € 50m cash budget spent so far) and/or higher-than-usual shareholder returns. Reiterating BUY at an unchanged PT of € 41.

You can download the research here: indus-holding-ag-2026-08-13-previewreview-en-84b5b
For additional information visit our website: https://www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2382046  13.08.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière